"10.1371_journal.pone.0082742","plos one","2013-12-17T00:00:00Z","Lihua E Budde; Carolina Berger; Yukang Lin; Jinjuan Wang; Xubin Lin; Shani E Frayo; Shaunda A Brouns; David M Spencer; Brian G Till; Michael C Jensen; Stanley R Riddell; Oliver W Press","Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California, United States of America; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Departments of Medicine and Bioengineering, University of Washington, Seattle, Washington, United States of America; Pathology and Immunology, Baylor College of Medicine, Houston, Texas, United States of America; Bellicum Pharmaceuticals, Inc., Houston, Texas, United States of America; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, Washington, United States of America; Institute for Advanced Study, Technical University of Munich, Munich, Germany","Conceived and designed the experiments: LEB CB SRR OWP. Performed the experiments: LEB YL JW XL. Analyzed the data: LEB CB YL JW XL SEF SAB BGT DMS MCJ SRR OWP. Contributed reagents/materials/analysis tools: DMS SRR. Wrote the paper: LEB CB YL JW XL SEF SAB BGT DMS MCJ SRR OWP.","The authors have read the journal's policy and the following authors have conflicts: DM Spencer: Employee of Bellicum Pharmaceuticals; and MC Jensen: Founder and equity holder in ZetaRx Biosciences Inc.; SAB and Consultant, ZetaRx Biosciences Inc. These competing interests do not alter the authors' adherence to all of the PLOS ONE policies on sharing data and materials.","2013","12","Lihua E Budde","LEB",12,TRUE,4,4,12,12,TRUE,TRUE,FALSE,0,NA,FALSE
